The common fusion partners of NSCLC, acute myeloid leukemia, and 8p11 myeloproliferative syndrome are transforming acidic coiled‐coil‐containing protein 1 (TACC1), FGFR1 oncogene partner 2, and breakpoint cluster region, respectively. This evidence concerns the gene FGFR1 and non-small cell lung carcinoma.